AMBALAL SARABHAI ENTERPRISES
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.74 | 1.49 | 6.16 | 3.83 | 1.83 |
| CEPS(Rs) | 1.21 | 1.85 | 6.46 | 4.15 | 2.35 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 17.89 | 17.08 | 15.64 | 9.64 | 5.84 |
| Tax Rate(%) | 14.59 | 24.55 | 12.87 | 9.79 | 5.38 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 4.81 | 5.04 | 12.50 | -0.92 | -1.38 |
| EBIT Margin(%) | 7.08 | 10.20 | 27.86 | 21.39 | 14.41 |
| Pre Tax Margin(%) | 3.70 | 8.65 | 26.85 | 19.47 | 11.80 |
| PAT Margin (%) | 3.16 | 6.53 | 23.39 | 17.57 | 11.17 |
| Cash Profit Margin (%) | 5.15 | 8.10 | 24.54 | 19.01 | 13.02 |
| Performance Ratios | |||||
| ROA(%) | 2.29 | 4.81 | 21.57 | 15.02 | 7.84 |
| ROE(%) | 4.24 | 9.13 | 48.74 | 49.47 | 40.95 |
| ROCE(%) | 7.15 | 11.18 | 45.53 | 40.28 | 27.14 |
| Asset Turnover(x) | 0.73 | 0.74 | 0.92 | 0.86 | 0.70 |
| Sales/Fixed Asset(x) | 1.72 | 2.02 | 2.89 | 2.44 | 2.06 |
| Working Capital/Sales(x) | 11.09 | 21.73 | 13.71 | -21.02 | -4.69 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.58 | 0.49 | 0.35 | 0.41 | 0.49 |
| Receivable days | 54.38 | 57.66 | 60.46 | 73.84 | 83.82 |
| Inventory Days | 34.09 | 33.90 | 28.13 | 35.41 | 41.50 |
| Payable days | 132.85 | 149.28 | 155.45 | 165.09 | 199.78 |
| Valuation Parameters | |||||
| PER(x) | 61.35 | 13.73 | 5.66 | 4.61 | 10.38 |
| PCE(x) | 37.66 | 11.07 | 5.40 | 4.26 | 8.11 |
| Price/Book(x) | 2.54 | 1.20 | 2.23 | 1.83 | 3.26 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 2.08 | 1.01 | 1.35 | 0.80 | 1.17 |
| EV/Core EBITDA(x) | 18.96 | 8.09 | 3.94 | 4.53 | 6.92 |
| EV/EBIT(x) | 28.31 | 9.65 | 4.71 | 3.68 | 7.81 |
| EV/CE(x) | 1.98 | 0.99 | 1.15 | 0.63 | 0.85 |
| M Cap / Sales | 2.01 | 0.92 | 1.36 | 0.83 | 1.09 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 1.93 | -13.45 | 20.23 | 22.58 | -12.10 |
| Core EBITDA Growth(%) | -10.80 | -68.28 | 131.58 | 29.13 | 98.01 |
| EBIT Growth(%) | -28.75 | -68.20 | 57.35 | 79.39 | 115.17 |
| PAT Growth(%) | -50.38 | -75.76 | 60.86 | 90.17 | 670.90 |
| EPS Growth(%) | -50.37 | -75.76 | 60.85 | 108.76 | 230.92 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.33 | 0.33 | 0.21 | 0.37 | 0.70 |
| Current Ratio(x) | 1.16 | 1.08 | 1.14 | 0.94 | 0.78 |
| Quick Ratio(x) | 1.00 | 0.91 | 1.00 | 0.81 | 0.66 |
| Interest Cover(x) | 2.09 | 6.60 | 27.54 | 11.17 | 5.52 |
| Total Debt/Mcap(x) | 0.13 | 0.28 | 0.10 | 0.20 | 0.21 |
Compare Financial Ratios of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹336.6 Cr | -10.6% | -22.4% | -6.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,303.0 Cr | -5.1% | -9.4% | 29.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹143,389.0 Cr | -7.3% | -10.9% | 53% | Stock Analytics | |
| CIPLA | ₹114,645.0 Cr | -1.4% | -6.7% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,449.5 Cr | -9% | -14.4% | 1.4% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹91,587.4 Cr | -7% | -5% | 22.6% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -10.6% |
-22.4% |
-6.4% |
| SENSEX | 0.1% |
-3.6% |
7.9% |
You may also like the below Video Courses
